LXRX Lexicon Pharmaceuticals, Inc.

NASDAQ
$1.80

Lexicon Pharmaceuticals, Inc. (LXRX) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $0.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -8.4% since its last earnings release on August 6, 2026.

Lexicon Pharmaceuticals Reported In-line with Estimates
Thursday, August 6, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 7:30 AM ET
Earnings Whisper
-
vs ($0.05)
Rev est $10.9M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.22

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.